THOMPSON PETER A. enters PRINCIPIA BIOPHARMA INC. with 3.94K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.94K | Direct |
| Total | 3.94K | 3.94K direct |
Series A Preferred Stock
IndirectUnderlying shares
1.07M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series C Preferred Stock
IndirectUnderlying shares
167.54K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series B-3 Preferred Stock
IndirectUnderlying shares
544.05K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Warrant to Purchase Series B-3 Preferred Stock
IndirectUnderlying shares
28.62K
Shares owned
N/A
Exercise price
8.9931
Expiration
—
Exercise window
—
Series B-2 Preferred Stock
IndirectUnderlying shares
260.62K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series B-1 Preferred Stock
IndirectUnderlying shares
312.74K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Underlying
2.38M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock | — | — | 1.07M | N/A | |
| Series C Preferred Stock Indirect | Common Stock | — | — | 167.54K | N/A | |
| Series B-3 Preferred Stock Indirect | Common Stock | — | — | 544.05K | N/A | |
| Warrant to Purchase Series B-3 Preferred Stock Indirect | Series B-3 Preferred Stock | 8.9931 | — | — | 28.62K | N/A |
| Series B-2 Preferred Stock Indirect | Common Stock | — | — | 260.62K | N/A | |
| Series B-1 Preferred Stock Indirect | Common Stock | — | — | 312.74K | N/A | |
| Total | 2.38M | 0.00 | ||||